Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy to Treat Advanced/Recurrent Epithelial Ovarian Cancer: Results from a Retrospective Study on Prospectively Established Database-Reference-Cited by-同舟云学术

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy to Treat Advanced/Recurrent Epithelial Ovarian Cancer: Results from a Retrospective Study on Prospectively Established Database

Published:2016-04 Issue:2 Volume:9 Page:130-138
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Sun Jian-Hua,Ji Zhong-He,Yu Yang,Wu Hai-Tao,Huang Chao-Qun,Zhang Qian,Yang Xiao-Jun,Yonemura Yutaka,Li Yan

Funder

Hubei Province’s Outstanding Medical Academic Leader Program

Science Fund for Doctorate Mentors by China’s Ministry of Education

Special Fund for Key Academic Discipline Development of Beijing Shijitan Hospital Affiliated to Capital Medical University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Ovarian cancer;Hennessy;Lancet,2009

2. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N Engl J Med,1996

3. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study;Ozols;J Clin Oncol,2003

4. Tertiary cytoreduction in patients with recurrent ovarian carcinoma;Leitao;Gynecol Oncol,2004

5. Critical appraisal of bevacizumab in the treatment of ovarian cancer;Yoshida;Drug Des Devel Ther,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nephrotoxicity Associated with Cytoreductive Surgery Combined with Cisplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignant Disease: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-06-28

2. The Potential Prognostic Impact of Associated Peritoneal Carcinomatosis in Patients with Stage II and III Epithelial Ovarian Cancer Who Had Upfront Complete Cytoreduction;The Journal of Obstetrics and Gynecology of India;2024-03-25

3. Prognostic role of the peritoneal cancer index in ovarian cancer patients who undergo cytoreductive surgery: a meta-analysis;Current Problems in Cancer;2023-12

4. Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer;World Journal of Surgical Oncology;2023-11-30

5. Outcomes Following Cytoreductive Surgery and Hyperthermic Intraoperative Thoraco-Abdominal Chemotherapy with Diaphragm Resection for Peritoneal Carcinomatosis: A Retrospective Cohort Study;Annals of Surgical Oncology;2023-10-22